Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ·Healthcare·Biotechnology
$508.14
+5.42%
Mkt Cap $11.14B
Analyst Ratings
Buy
5
Hold
2
Sell
0
Price Target (35 analysts)
$656.00
Range $542.00 – $964.00
Implied Upside
+29.1%
Consensus $656.00 vs current $508.14